Home > Drug Search >
  • company_query: Aptinyx
  •   > 
Drug Filter
Category:
chemistry (11) biology (19)
Status:
Approved (1) BLA Filing (2) Phase Ⅱ (12) Phase Ⅰ (15)
Clinical Stage:
Pending (6) Active (21) Discontinued (2)
Bio-Type:
Gene therapy (4) Cell therapy (1) Vaccine (7) Recombinant enzyme (1) Bispecific antibody (1) Whole antibody (3)
Indication:
Clostridium difficile infection (1) Erectile dysfunction (ED) (1) Follicular lymphoma (1) HBV infection (2) Heart failure (1) Rabies (1) Melanoma (1) Multiple sclerosis (MS) (1) Peptic ulcer (1) Pneumonia (1) Postmenopausal osteoporosis (1) Measles (1) Psoriasis (1) Rheumatoid arthritis (RA) (1) Solid tumours (7) Leber congenital amaurosis (1) Type 2 diabetes (1) Ulcerative colitis (1) Colorectal cancer (2) Sarcoma (1) Sickle cell disease (1) Hemophilia B (2) Alcoholism (1) Thelassemia (1) Neurological disease (1) Sciatica (1) Inflammation (1) Nontuberculous Mycobacteria (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top